实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.
作者信息
Boyarsky Brian J, Werbel William A, Avery Robin K, Tobian Aaron A R, Massie Allan B, Segev Dorry L, Garonzik-Wang Jacqueline M
机构信息
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
Abstract
This follow-up study measures the antibody response following the second dose of SARS-CoV-2 mRNA vaccine in recipients of solid organ transplants.
摘要
这项随访研究测量了实体器官移植受者在接种第二剂SARS-CoV-2 mRNA疫苗后的抗体反应。
相似文献
1
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.实体器官移植受者对两剂严重急性呼吸综合征冠状病毒2信使核糖核酸疫苗系列的抗体反应。
JAMA. 2021 Jun 1;325(21):2204-2206. doi: 10.1001/jama.2021.7489.
2
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.mRNA 疫苗在实体器官移植受者中的单剂免疫原性。
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
3
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.SARS-CoV-2 mRNA-1273疫苗接种后反应的持久性。
N Engl J Med. 2021 Jan 7;384(1):80-82. doi: 10.1056/NEJMc2032195. Epub 2020 Dec 3.
4
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.严重急性呼吸综合征冠状病毒2型信使核糖核酸疫苗在曾感染2019冠状病毒病的实体器官移植受者中的免疫原性
Transplantation. 2021 Nov 1;105(11):e270-e271. doi: 10.1097/TP.0000000000003900.
5
Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients.实体器官移植受者对杨森新冠疫苗的抗体反应。
Transplantation. 2021 Aug 1;105(8):e82-e83. doi: 10.1097/TP.0000000000003850.
6
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.肾移植受者同源与异源第三剂疫苗接种后 4 周时的 SARS-CoV-2 抗体反应比较：一项随机临床试验。
JAMA Intern Med. 2022 Feb 1;182(2):165-171. doi: 10.1001/jamainternmed.2021.7372.
7
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.新型冠状病毒刺突蛋白受体结合域线性表位在 COVID-19 mRNA 疫苗接种者中的高分辨率线性表位作图。
Microbiol Spectr. 2021 Dec 22;9(3):e0096521. doi: 10.1128/Spectrum.00965-21. Epub 2021 Nov 10.
8
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗接种的实体器官移植受者的抗体动力学和持久性
Transplantation. 2021 Oct 1;105(10):e137-e138. doi: 10.1097/TP.0000000000003863.
9
SARS-CoV-2 anti-spike IgG antibodies are present in all liver transplant recipients after fifth vaccine dose.在接受第五剂疫苗后，所有肝移植受者体内均存在新冠病毒抗刺突IgG抗体。
J Hepatol. 2024 Jun;80(6):e284-e286. doi: 10.1016/j.jhep.2023.12.008. Epub 2023 Dec 16.
10
Could mixing COVID vaccines boost immune response?混合接种新冠疫苗能增强免疫反应吗？
Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5.
引用本文的文献
1
Correlates of SARS-CoV-2 Breakthrough Infections in Kidney Transplant Recipients Following a Third SARS-CoV-2 mRNA Vaccine Dose.肾移植受者接种第三剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗后SARS-CoV-2突破性感染的相关因素
Vaccines (Basel). 2025 Jul 22;13(8):777. doi: 10.3390/vaccines13080777.
2
Post-COVID-19 cardiovascular disease risk in kidney transplant recipients.肾移植受者中新冠病毒感染康复后的心血管疾病风险
Am J Transplant. 2025 Jul 15. doi: 10.1016/j.ajt.2025.07.2462.
3
Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients.系统疫苗学确定了实体器官移植受者中SARS-CoV-2疫苗反应的免疫相关因素。
NPJ Vaccines. 2025 Jul 1;10(1):140. doi: 10.1038/s41541-025-01182-1.
4
Long-Term Immuno-Response and Risk of Breakthrough Infection After SARS-CoV-2 Vaccination in Kidney Transplantation.肾移植受者接种 SARS-CoV-2 疫苗后的长期免疫反应及突破性感染风险
Vaccines (Basel). 2025 May 26;13(6):566. doi: 10.3390/vaccines13060566.
5
Who is the Candidate? The Heart Transplant Evaluation Process.谁是候选人？心脏移植评估过程。
Methodist Debakey Cardiovasc J. 2025 May 15;21(3):13-24. doi: 10.14797/mdcvj.1512. eCollection 2025.
6
High Rate of Antibody Response to Multiple Doses of the COVID-19 Vaccine in Liver Transplant Recipients: Analysis of Predictive Factors.肝移植受者对多剂新冠疫苗的高抗体反应率：预测因素分析
Vaccines (Basel). 2025 Mar 26;13(4):352. doi: 10.3390/vaccines13040352.
7
Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney transplant recipients.揭示白细胞介素-2和白细胞介素-5在肾移植受者中针对严重急性呼吸综合征冠状病毒2特异性T细胞反应中的意义。
Npj Viruses. 2024 Feb 14;2(1):7. doi: 10.1038/s44298-024-00015-7.
8
Immunogenicity and Safety of the Bivalent Respiratory Syncytial Virus Prefusion F Subunit Vaccine in Immunocompromised or Renally Impaired Adults.二价呼吸道合胞病毒预融合F亚单位疫苗在免疫功能低下或肾功能受损成人中的免疫原性和安全性
Vaccines (Basel). 2025 Mar 19;13(3):328. doi: 10.3390/vaccines13030328.
9
Efficacy of COVID-19 Vaccination in People Living with HIV/AIDS in a Northern Brazil: Cross-Sectional Study.巴西北部艾滋病毒/艾滋病感染者中新冠疫苗接种的效果：横断面研究
Vaccines (Basel). 2025 Mar 7;13(3):283. doi: 10.3390/vaccines13030283.
10
mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients.mRNA-1273新冠疫苗可在实体器官移植受者中诱导CD4+ T细胞应答。
Front Immunol. 2025 Apr 3;16:1505871. doi: 10.3389/fimmu.2025.1505871. eCollection 2025.
Zotero 插件